Public ID: PID-94YRRB
Restriction on exporting pharmaceuticals to Bangladesh
Trade barrier summary
This affects UK exporters of pharmaceutical products to Bangladesh. Prior approval from the Directorate General of Drug Administration (DGDA) of the Ministry of Health and Family Welfare is required to export pharmaceutical products to Bangladesh. The importer, along with the other details of the drug, needs to submit the intended quantity of import for approval - the quantity is often dictated by the demand for that specific brand in the market.
Recently DGDA has been approving significantly lower quantities than requested, which is creating a problem for importers. Restricting the quantity that can be imported means unmet demand remains in the market, and market shortages affect consumer trust in the brand.
- Pharmaceuticals and biotechnology
23 May 2019
18 December 2020